Quotables
"The man with a new idea is a crank until the idea succeeds."
Samuel Clemens
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7807720 | Hydroxamic acid derivatives of 3-phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning Compounds having the formula wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of 3-phenyl-propionic acid and capable of inhibiting the lethal effects of infection by anthra... | 10/05/2010 |
| 7806920 | Sigmoid valve and method for its percutaneous implantation A multi-leaflet valve adapted to serve as a prosthesis for diseased native valve of a mammal is incorporated in self-expandable or inflatable endovascular stents or stents to form a combination which is introduced on a catheter with a guide wire into the circulatory... | 10/05/2010 |
| 7802566 | Portable barbecue set and kit A barbecue kit includes a threaded rod having a bore in its interior along its longitudinal axis. An elongated stake having a sharp and a blunt end loosely fits into the interior bore of the threaded rod. The combination of rod and stake include a functional mechani... | 09/28/2010 |
| 7762535 | Stave press A stave press assembly for holding a wooden stave or other work piece while the stave is fabricated into a bow or other operations are performed on the work piece, has an immovable pressure plate disposed nominally horizontally when the press is attached to a suppor... | 07/27/2010 |
| 7407795 | Method for growing on a substrate and novel method for hybridizing different strains of Two different strains of Cordyceps sinensis are placed at two different locations in a medium containing purified rattle snake venom and the two strains are allowed to grow until they meet in a boundary zone where a hybrid strain is formed due to exchange of ... | 08/05/2008 |
| 7351737 | 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity Compounds of the formula where the variables are defined in the specification have cytochrome P450RAI-1 and P450RAI-2 inhibitory activity, and are suitable for treatment of mammals with conditions which are treatable with r... | 04/01/2008 |
| 7345077 | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds Compounds of Formula 1 where X is S and the variables have the meaning defined in the specification are specific or selective to alpha2B and/or alpha2C adrenergic receptors in ... | 03/18/2008 |
| 7294716 | Process for preparing isomerically pure prodrugs of proton pump inhibitors Synthetic methods for preparing isomerically pure N-arylsulfonyl derivatives of proton pump inhibitors which include a substituted benzimidazole nucleus are shown by the synthetic schemes and experimental description. ... | 11/13/2007 |
| 7276522 | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds The compound of the formula wherein the * indicates an asymmetric carbon, is specific to alpha2B adrenergic receptors in preference over alpha2A and alpha2C adrenergic receptors, ... | 10/02/2007 |
| 7226626 | Food products and dietary supplements containing phenolated proteins and process for preparing the same Novel food, dietary supplement and nutraceutical products containing phenol/protein complexes derived from vegetable sources have high antioxidant activity and very high levels of protein. The products provide novel means for administering high levels of plant antio... | 06/05/2007 |
| 7160320 | Reed valve for implantation into mammalian blood vessels and heart with optional temporary or permanent support A multi-leaflet valve adapted to serve as a prosthesis for diseased native valve of a mammal is constructed of biologic membrane or of biocompatible synthetic membrane. The valve has the shape of a truncated cone that has an inflow and an outflow orifice with leafle... | 01/09/2007 |
| 7160972 | Optically clear high temperature resistant silicone polymers of high refractive index A thermally stable polysiloxane composition is a cross-linked product of a Part A composition, of a Part B composition and a catalyst, the Part A composition being a polysiloxane having 60 to 75 percent by weight phenyl groups, the Part B composition being a polysil... | 01/09/2007 |
| 7125418 | Sigmoid valve and method for its percutaneous implantation A multi-leaflet valve adapted to serve as a prosthesis for diseased native valve of a mammal is incorporated in self-expandable or inflatable endovascular stents or stents to form a combination which is introduced on a catheter with a guide wire into the circulatory... | 10/24/2006 |
| 7091232 | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds Compounds of Formula 1 where X is S and the variables have the meaning defined in the specification are specific or selective to alpha2B and/or alpha2C adrenergic re... | 08/15/2006 |
| 7026487 | Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity Compounds of the formula where the symbols are as defined in the specification, have retinoid agonist, antagonist or negative hormone-like biological activity. ... | 04/11/2006 |
| 7019034 | Compositions and methods for reducing serum glucose and triglyceride levels in diabetic mammals Diabetic mammals are treated with compounds that are significantly more efficacious as agonists of RXRβ retinoid receptors than as agonists of RXRα or RXRγ retinoid receptors. The treatment reduces serum glucose and triglyceride l... | 03/28/2006 |
| 7004101 | Boat with stabilizer adapted to serve as loading platform The hull of a boat includes an opening which is closed by a door attached to the hull with a hinge and capable of limited pivoting motion on the hinge with a substantially horizontal axis of the pivot. In its upright first extreme position the door comprises a part ... | 02/28/2006 |
| 6936636 | 5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity Compounds of the formula: where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effects... | 08/30/2005 |
| 6923509 | Cargo trailer anti-terrorist and anti-theft system A remotely activated electro mechanical device is mounted in the dual chamber brake system of a vehicle or trailer. The device includes a solenoid valve and a receiver decoder which controls the valve in response to a coded signal ideally available only to law enfor... | 08/02/2005 |
| 6904863 | Self-retracting lockable step-assembly for boats A self-retracting step assembly is attached to a swimming platform provided on the rear of the hull of a boat. The self-retracting step assembly includes a ladder comprising a series of telescoping tubes which enable its extension and retraction. The step assembly i... | 06/14/2005 |
| 6897227 | Prodrugs of proton pump inhibitors Prodrugs of proton pump inhibitors of Formulas 1 through 4, where the symbols are as defined in the specification, and the R group includes at least one acidic group or its pharmaceutically acceptable salt, have improv... | 05/24/2005 |
| 6890961 | Clear micellized formulations of β-carotene and method of treating leukoplakia A clear aqueous formulation for topical application in the oral cavity of humans to treat leukoplakia contains water, β-carotene, a water miscible polyol, an unsaturated fatty acid ester, and a surfactant, preferably polyethoxylated castor oil or POE(20) sorbitan m... | 05/10/2005 |
| 6887896 | 7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity Compounds of the formula where the variations have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effects of transiently increasin... | 05/03/2005 |
| 6884820 | 5,6,7,8-tetrahydronaphthalen-2-yl-7-fluoroalkyl-heptatrienoic acid derivatives having serum glucose reducing activity Compounds of the formula where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effect of reducing serum thyroxin... | 04/26/2005 |
| 6864282 | 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma 9,11-Cycloendoperoxide derivatives of biologically active prostaglandin analogs, and particularly of the ocular hypotensive drugs Bimatoprost, Latanaprost, Unoprostone, Travoprost and prostaglandin H2 1-ethanolamide or of structurally closely related anal... | 03/08/2005 |
| 6855512 | Methods for identifying inhibitors of cytochrome P450RAI A method of identifying a compound which is an inhibitor of the enzyme cytochrome P450RAI is performed by selecting a compound that has retinoid activity in an art recognized assay and includes a benzoic acid, benzoic acid ester, naphthoic acid ester or heteroaryl c... | 02/15/2005 |
| 6855832 | O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity Compounds of the formula where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity. ... | 02/15/2005 |
| 6818775 | Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity Compounds of the formula where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity. ... | 11/16/2004 |
| 6759547 | 5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity Compounds of the formula where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effect of reducing serum thyroxine ... | 07/06/2004 |
| 6759436 | Clear micellized formulations of β-carotene and method of treating leukoplakia A clear aqueous formulation for topical application in the oral cavity of humans to treat leukoplakia contains water, β-carotene, a water miscible polyol, an unsaturated fatty acid ester, and a surfactant, preferably polyethoxylated castor oil. The formulation pref... | 07/06/2004 |
| 6759546 | 3,5-di-iso-propyl-heptatrienoic acid derivatives having serum glucose reducing activity Compounds of the formula where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effect of reducing serum thyroxine ... | 07/06/2004 |
| 6753312 | Food products and dietary supplements containing phenolated proteins and process for preparing the same Novel food, dietary supplement and nutraceutical products containing phenol/protein complexes derived from vegetable sources have high antioxidant activity and very high levels of protein. The products provide novel means for administering high levels of plant antio... | 06/22/2004 |
| 6740676 | 4-[(8-ETHYNYL, 8-VINYL OR 8-ETHYNYL-METHYL)-6-CHROMANOYL]-BENZOIC AND 2-[4-[(8-ETHYNYL, 8-VINYL OR 8-ETHYNYL-METHYL)-6-CHROMANOYL]-PHENYL]-ACETIC ACID, THEIR ESTERS AND SALTS HAVING CYTOCHROME P450RAI INHIBITORY ACTIVITY Compounds of Formula 1: wherein the variables are defined in the specification have cytochrome P450RAI-1 and P450RAI-2 inhibitory activity, and are suitable for treatment of mammals with conditions which are treatable wi... | 05/25/2004 |
| 6734193 | (1,2,3,4-tetrahydroquinolin-8-yl)-heptatrienoic acid derivatives having serum glucose reducing activity Compounds of the formula where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effects of reducing serum thyroxine... | 05/11/2004 |
| 6720423 | Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors Compounds of the formula where the variables have the meaning defined in the specification, are specific or selective agonists of RXR retinoid receptors. ... | 04/13/2004 |
| 6720425 | Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity Compounds of the formula where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity. ... | 04/13/2004 |
| 6713647 | Compounds having activity as inhibitors of cytochrome P450RAI Compounds having Formula 4 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids. ... | 03/30/2004 |
| 6661168 | Low voltage incandescent lamp with dual envelope A miniature or subminiature incandescent lamp designed to operate with an energy source of 20 volts or less includes a filament enclosed in a first glass envelope and supported by a pair of metal contact pins. A first glass bead seals the envelope and has... | 12/09/2003 |
| 6649208 | Apparatus and method for thin film deposition onto substrates An apparatus for depositing thin films on a plurality of substrates has a vacuum chamber, a source of the material or materials to be deposited as the thin film, a source of energy for causing the material to be vaporized, and mechanical apparatus for imp... | 11/18/2003 |
| 6630001 | Compliant dehyrated tissue for implantation and process of making the same A process for preparing pliable soft tissue specimen which are resistant to cracking and devoid of viable cells includes the steps of treating native soft tissue obtained from a donor by a gradually increasing gradient of aliphatic alcohol or other suitab... | 10/07/2003 |
